Follow
Pedro Romero
Pedro Romero
Professor of Civil Engineering, University of Utah
Verified email at utah.edu - Homepage
Title
Cited by
Cited by
Year
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
KF Bol, G Schreibelt, K Rabold, SK Wculek, JK Schwarze, A Dzionek, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
1572019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
B Mastelic-Gavillet, B Navarro Rodrigo, L Décombaz, H Wang, ...
Journal for immunotherapy of cancer 7, 1-16, 2019
1502019
Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
Q Haas, KF Boligan, C Jandus, C Schneider, C Simillion, MA Stanczak, ...
Cancer immunology research 7 (5), 707-718, 2019
1022019
Expression of killer inhibitory receptors on cytotoxic cells from HIV‐1‐infected individuals
GALIANI, AGUADO, TARAZONA, ROMERO, MOLINA, SANTAMARIA, ...
Clinical & Experimental Immunology 115 (3), 472-476, 1999
951999
Tumor resident memory T cells: new players in immune surveillance and therapy
N Dumauthioz, S Labiano, P Romero
Frontiers in immunology 9, 411458, 2018
922018
Very late antigen-1 marks functional tumor-resident CD8 T cells and correlates with survival of melanoma patients
T Murray, SA Fuertes Marraco, P Baumgaertner, N Bordry, L Cagnon, ...
Frontiers in immunology 7, 573, 2016
922016
ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells
M Lecciso, D Ocadlikova, S Sangaletti, S Trabanelli, E De Marchi, E Orioli, ...
Frontiers in immunology 8, 319887, 2017
832017
Enforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity
N Dumauthioz, B Tschumi, M Wenes, B Marti, H Wang, F Franco, W Li, ...
Cellular & molecular immunology 18 (7), 1761-1771, 2021
812021
Future perspectives in melanoma research: Meeting report from the “Melanoma Bridge”. Napoli, December 1st–4th 2015
PA Ascierto, S Agarwala, G Botti, A Cesano, G Ciliberto, MA Davies, ...
Journal of translational medicine 14, 1-25, 2016
802016
CART cells are prone to Fas-and DR5-mediated cell death
BO Tschumi, N Dumauthioz, B Marti, L Zhang, P Schneider, JP Mach, ...
Journal for immunotherapy of cancer 6 (1), 71, 2018
752018
18F-FDG PET metabolic-to-morphological volume ratio predicts PD-L1 tumour expression and response to PD-1 blockade in non-small-cell lung cancer
M Jreige, I Letovanec, K Chaba, S Renaud, S Rusakiewicz, V Cristina, ...
European journal of nuclear medicine and molecular imaging 46, 1859-1868, 2019
742019
Positional scanning-synthetic peptide library-based analysis of self-and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL
V Rubio-Godoy, V Dutoit, Y Zhao, R Simon, P Guillaume, R Houghten, ...
The Journal of Immunology 169 (10), 5696-5707, 2002
692002
Improving protein order-disorder classification using charge-hydropathy plots
F Huang, CJ Oldfield, B Xue, WL Hsu, J Meng, X Liu, L Shen, P Romero, ...
BMC bioinformatics 15, 1-13, 2014
682014
Analysis of the kinetics of transcription and replication of the rotavirus genome by RNA interference
C Ayala-Breton, M Arias, R Espinosa, P Romero, CF Arias, S López
Journal of virology 83 (17), 8819-8831, 2009
682009
Autocrine Adenosine Regulates Tumor Polyfunctional CD73+CD4+ Effector T Cells Devoid of Immune Checkpoints
N Gourdin, M Bossennec, C Rodriguez, S Vigano, C Machon, C Jandus, ...
Cancer research 78 (13), 3604-3618, 2018
672018
Immuno-monitoring of CD8+ T cells in whole blood versus PBMC samples
V Appay, S Reynard, V Voelter, P Romero, DE Speiser, S Leyvraz
Journal of immunological methods 309 (1-2), 192-199, 2006
632006
A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: implication for molecular anti-melanoma immunotherapy
JS Blanchet, D Valmori, I Dufau, M Ayyoub, C Nguyen, P Guillaume, ...
The Journal of Immunology 167 (10), 5852-5861, 2001
632001
Activation of human melanoma reactive CD8+ T cells by vaccination with an immunogenic peptide analog derived from Melan-A/melanoma antigen recognized by T cells-1
M Ayyoub, A Zippelius, MJ Pittet, D Rimoldi, D Valmori, JC Cerottini, ...
Clinical cancer research 9 (2), 669-677, 2003
622003
Expression of melan‐a/MART‐1 antigen as a prognostic factor in primary cutaneous melanoma
M Berset, JP Cerottini, D Guggisberg, P Romero, F Burri, D Rimoldi, ...
International journal of cancer 95 (1), 73-77, 2001
612001
Survival of pathogenic microorganisms in seawater
R Cornax, MA Moriñigo, P Romero, JJ Borrego
Current microbiology 20, 293-298, 1990
601990
The system can't perform the operation now. Try again later.
Articles 1–20